Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News and Analysis
  • Published:

Drug repurposing programmes get lift off

Nature Reviews Drug Discovery volume 11, pages 505–506 (2012)Cite this article

Subjects

What will schemes designed to get industry's discarded drug candidates into the hands of academic researchers deliver?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Breakdown of the US National Institute of Health's repurposing assets by therapeutic area.
Authors
  1. Asher Mullard
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mullard, A. Drug repurposing programmes get lift off. Nat Rev Drug Discov 11, 505–506 (2012). https://doi.org/10.1038/nrd3776

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3776

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research